Blood Flow Restriction (BFR) Training Effects, Exercise, Supplement
Conditions
Keywords
NMN, vitamin C, exercise, BFR
Brief summary
In this 3-year project, investigators will first measure stem cells (primary outcome) and immune cells (secondary outcome) in human skeletal muscle immediately after and 24 hour after the BFR-training. In the second and third year, the effect of β-NMN (vitamin B3 precursor) and antioxidant on the same outcomes after BFR-exercise will be assessed. The BFR-exercise in the study will consist of a 5 × 10-second sprinting with maximal voluntary efforts, 5 minutes after a BFR pre-conditioning to legs using pressurized cuffs. In Study 1 (1st year, N = 24, aged 20-30 year), a randomized crossover trial will be conducted to compare the efficacy of sprinting exercise using BFR pre-conditioning at 20 mmHg (control) or 180 mmHg (occlusion). Study 2 (2nd year, N = 24, aged 20-30 years) will be conducted to examine the effect of β-NMN supplementation on the aforementioned outcomes in human muscles using a randomized placebo-controlled crossover study design. Study 3 (third year, N = 24, aged 20-30 years) will be conducted to examine the effect of vitamin C on the same variables immediately after and 24 hours after resistance exercise intervention, using a randomized placebo-controlled crossover study design.
Detailed description
Primary outcome: Stem cells (Stro-1+ cells) assessed by immunofluorescence staining. Secondary outcome: Immune cells (MPO+ cells) assessed by immunofluorescence staining. Study 1: Two-arm intervention (counterbalanced crossover design): Sham-exercise, BFR-exercise Study 2: Two-arm intervention (counterbalanced crossover design): Placebo-BFR exercise, NMN-BFR exercise Study 3: Two-arm intervention (counterbalanced crossover design): Placebo-BFR exercise, Vitamin C-BFR exercise
Interventions
Sprinting exercise after BFR
NMN ingested before and after BFR exercise
Vitamin C ingested before and after resistance exercise
Sponsors
Study design
Intervention model description
Three studies will be conducted: Study 1: 2-arm Study 2: 2-arm Study 3: 2-arm
Eligibility
Inclusion criteria
* healthy men
Exclusion criteria
* inflammatory or immune conditions
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Stem cells in muscle | Pre-exercise, immediately post-exercise, and 24-hour post-challenge (BFR-exercise) recovery | Stem cells are identified by Stro-1 cell marker |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Immune cells in muscle | At 24-hour post-challenge recovery | Immune cells are identified by myeloperoxidase (MPO) cell marker |
Countries
Taiwan